Xenix Medical earned FDA 510(k) clearance for its Lux expandable lumbar interbody fusion system, and the device is available in a full commercial launch.
The Lux system allows for significant post-expansion bone graft packing and features Xenix Medical’s NanoActiv surface, according to a June 8 news release. Key features include up to 4.5mm of post-implantation expansion, subsidence mitigation through NeoWave matrix architecture and a large endplate-to-endplate graft window.
“I have always found the concept of expandable cages to be appealing, since minimally invasive surgery is a big part of my clinical practice,” Robert Hirschl, MD, Xenix Medical’s founder said in the release. “They can be placed through smaller incisions and access windows while minimizing the risk of neural injury or CSF leaks. However, I have avoided using them until now because they have historically suffered from lower fusion rates and greater subsidence than static devices. Lux was developed to address these shortcomings with its large open graft window, NanoACTIV surface technology, and NeoWave endplates and side walls. The early results have been extremely encouraging as expected.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
